BC Partners is nearing a deal to sell Dutch generic drugmaker Synthon International Holding BV to Goldman Sachs Asset ...

Buddy Chester LLC, an entity affiliated with private equity firm BC Partners, will commence a public offering of $500 million ...

BC Partners has agreed to sell its majority stake in Synthon to Goldman Sachs Alternatives. Synthon is an international pharmaceutical company, with a platform specialized in developing, manufacturing ...

Goldman Sachs Group Inc.’s alternative investment arm has agreed to buy a majority stake in Dutch generic drugmaker Synthon from BC Partners.

Goldman Sachs Asset Management has agreed a more than €2bn deal to acquire drugmaker Synthon from BC Partners, according to people familiar with the matter, as it hopes to capitalise on demand for off ...

Goldman Sachs’ asset arm is in the process of acquiring the Dutch pharmaceutical company Synthon International for 2 billion ...

Innergex Renewable Energy Inc. (TSX: INE) ("Innergex" or the "Corporation") is proud to announce that three of its wind projects, co-developed with Indigenous partners, have been selected in BC ...

Fraser Health has launched a public awareness campaign encouraging pregnant people and people with syphilis symptoms to get ...

The Conservative Party of B.C. says government officials should have been more aggressive in scrutinizing the finances of ...

Where will growers go for supplies now that BC Growers Supply is closing following its operator, BC Fruit Trees, applying for ...

Valdrez said a syphilis blood test ideally happens during the first trimester so there are at least four weeks between when ...

All four lanes of Independence Bridge will be open by the end of the month, and tolling on the bridge will begin at the start ...